findmyKOL
Clinical trialNCT05557877RecruitingPhase 2Interventional

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

SponsorMayo ClinicEnrollment60Breast Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. Chronic inflammation may increase the risk of postpartum related breast cancer. Low-dose aspirin is a non-steroidal anti-inflammatory drug. Giving low-dose aspirin may affect markers of inflammation in blood and tissue and may prevent postpartum related breast cancer.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic in Arizona

    Scottsdale, Arizona, United States

    Terminated
  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

    Santo Maimone IV, MD
    Recruiting
  • Indiana University Simon Comprehensive Cancer Center

    Indianapolis, Indiana, United States

    Tarah Ballinger, MD
    Recruiting
  • Mayo Clinic in Rochester

    Rochester, Minnesota, United States

    Kathryn J. Ruddy, MD
    Recruiting
  • University of North Carolina

    Chapel Hill, North Carolina, United States

    Kristalyn Gallagher, DO
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Low-Dose Aspirin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Mar 2023
Primary completion
30 Jan 2027
Completion
30 Jan 2027
Last update posted
20 Aug 2026
Registered enrollment
60
Registry id
NCT05557877
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.